These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18442476

  • 1. An enzyme immunoassay for determining 17alpha-hydroxyprogesterone in dried blood spots on filter paper using an ultramicroanalytical system.
    González EC, Marrero N, Pérez PL, Frómeta A, Zulueta O, Herrera D, Martínez L, Castells E.
    Clin Chim Acta; 2008 Aug; 394(1-2):63-6. PubMed ID: 18442476
    [Abstract] [Full Text] [Related]

  • 2. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 3. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Aug; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 4. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G, García de la Rosa I, González Reyes EC, Rubio Torres A, Quintana Guerra JM, Hernández Marín M, Pérez Mora PL, Feal Carballo S, Lafita Delfino Y, Pupo Infante M, Castells Martínez EM, Rosabal Poloshkov A, Hernández Pérez L.
    Clin Chim Acta; 2018 Oct; 485():311-315. PubMed ID: 30006291
    [Abstract] [Full Text] [Related]

  • 5. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of an indirect enzyme immunoassay using monoclonal antibodies for the measurement of 17alpha-hydroxyprogesterone in human serum.
    Chong H, Cheah SH, Ragavan M, Johgalingam VT.
    J Immunoassay Immunochem; 2009 Jan; 30(2):166-79. PubMed ID: 19330642
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R.
    Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS.
    Higashi T, Nishio T, Uchida S, Shimada K, Fukushi M, Maeda M.
    J Pharm Biomed Anal; 2008 Sep 10; 48(1):177-82. PubMed ID: 18571354
    [Abstract] [Full Text] [Related]

  • 14. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun 10; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 15. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul 10; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 16. Usefulness and limitations of an in-house direct radioimmunoassay for 17-hydroxyprogesterone in serum.
    Lo MS, Ng ML, Wu LL, Azmy BS, Khalid BA.
    Malays J Pathol; 1996 Jun 10; 18(1):43-52. PubMed ID: 10879224
    [Abstract] [Full Text] [Related]

  • 17. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
    González EC, Frómeta A, del Río L, Castells E, Robaina MS, García SM, Licourt T, Arteaga AL, Martínez L.
    Clin Chim Acta; 2009 Apr 10; 402(1-2):129-32. PubMed ID: 19168043
    [Abstract] [Full Text] [Related]

  • 18. Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: reference ranges throughout childhood and adolescence.
    Dressendorfer RA, Strasburger CJ, Bidlingmaier F, Klug I, Kistner A, Siebler T, Kiess W.
    Pediatr Res; 1998 Nov 10; 44(5):650-5. PubMed ID: 9803445
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation.
    Deng C, Ji J, Zhang L, Zhang X.
    Rapid Commun Mass Spectrom; 2005 Nov 10; 19(20):2974-8. PubMed ID: 16178052
    [Abstract] [Full Text] [Related]

  • 20. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
    Janzen N, Sander S, Terhardt M, Steuerwald U, Peter M, Das AM, Sander J.
    Steroids; 2011 Dec 11; 76(13):1437-42. PubMed ID: 21839763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.